Indus Pharma Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 315

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Indus Pharma General Information

Description

Developer and manufacturer of branded generic pharmaceutical products intended to lead the way in the research and development, manufacture and marketing of a wide variety of generic pharmaceuticals in diverse therapeutic avenues. The company offers novel drugs for the treatment of cancer, infectious diseases and diabetes including antibiotics, vitamin supplements, analgesics and general anesthesia and also offers drug development and drug discovery services, thereby ensuring easy access to generic drugs for patients.

Contact Information

Website
www.indus-pharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
BetterLife Pharma
Primary Office
  • Plot No.A-26, Karachi Cooperative Housing Society
  • Union commercial area Block 7/8 shaheed-e-millat road
  • Karachi, 75400
  • Pakistan
+92 (021) 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indus Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Indus Pharma‘s full profile, request access.

Request a free trial

Indus Pharma Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Indus Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2869557-A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment Inactive 06-Apr-2012 00000000000
EP-2833883-A4 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment Inactive 06-Apr-2012 00000000000 0
EP-2833883-A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment Inactive 06-Apr-2012 00000000000
US-20150056192-A1 Novel compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment Active 06-Apr-2012 00000000000
US-9744175-B2 Compositions of combinations of non-covalent dna binding agents and anti-cancer and/or anti-inflammatory agents and their use in disease treatment Inactive 06-Apr-2012 A61K31/5517
To view Indus Pharma’s complete patent history, request access »

Indus Pharma Executive Team (2)

Name Title Board Seat Contact Info
Zahid Saeed Chief Executive Officer, Chairman & Managing Director
You’re viewing 1 of 2 executive team members. Get the full list »

Indus Pharma Board Members (1)

Name Representing Role Since
00000 000000 Indus Pharma Chairman 000 0000
To view Indus Pharma’s complete board members history, request access »

Indus Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial